Neurostyle Launch Event

Author :

Naraghi's Charity

Date: :

July 17, 2024

Dr. Roxana Kia, CEO of Nexus Pharmaceutical Company (subsidiary company of Actoverco) announced that Neurostyle, produced in tablet form by Nexus specialists, can be used by both ordinary individuals and those with diabetes who have difficulties with medication injections.

Nexus has distributed new products in the form of tablets, soft gels, and effervescent tablets, and plans to produce and market sachets and oral vials in the near future. She announced plans for a serious entry into the export market for these supplements.

Related News

Nahaleh Naraqi honors Pharmacy Day with a special message!

August 27, 2024

nahale naraqi

Nahale Naraghi honors National Doctors Day in Iran!

August 22, 2024

Treatment and Reduction of Menopause Symptoms with New Drugs by “Atipharmed”

August 10, 2024

Visual Report on the Introduction of Actonib and Its application in Dermatology

July 31, 2024

Production of the first drug approved by FDA for the treatment of severe alopecia areata in Iran

July 31, 2024

Neurostyle Launch Event

July 17, 2024